Promotion of chemical carcinogenesis and P53 expression by reduction of superoxide dismutase activity in the lung of ratin vivo
Tóm tắt
In the present experiment, an inhibitor of superoxide dismutase (SOD), diethyldithiocarbamate (DETC), was used to decrease SOD activity for the observation of the relation between SOD activity and carcinogenesis and the expression of P53 proteinin vivo. 144 Wistar rats were used for the present study. The results showed that the SOD activity reduction by DETC resulted markedly in the promotion of the carcinogenesis and the expression of P53 protein in the lung tissues, but the increase of SOD activity by the addition of plus SOD inhibited the pathological changes significantly. The frequency of the pathological lesions and positive P53 expression are 36/42 and 8/42 in the animals without DETC and SOD; 16/52 and 4/52 in the animals with SOD and 46/50 and 26/50 in the animals with DETC respectively. The results reported in this paper suggest that: (1) the decrease of SOD activity enhanced the carcinogenesis induced by chemical carcinogen; (2) P53 gene may be associated with the process of tumorigenesis; and (3) at the same time the abnormal expression of P53 protein may be associated with the transition from premalignant lesions to carcinoma.
Tài liệu tham khảo
Oberley LW, Buettner GR. Role of superoxide dismutase in cancer: A review. Cancer Res 1979; 39:1141.
Hollingsworth RE, Lee WH. Tumor suppressor genes: New prospects for cancer research. JNCI 1991; 83(2): 91.
Weinberb RA. Tumor suppressor genes. Science 1991; 254:1138.
Hsu IC, Metcalf RA, Sun T, et al. Mutational hotspot in the P53 gene in human hepatocellular carcinomas. Nature (London) 1991; 350:427.
Sidransky D, Von Eschenbach A, Tsai YC, et al. Identification of P53 gene mutations in bladder cancers and urine samples. Science (Washington DC) 1991; 252:706.
Cheng J, Haas M. Frequent mutations in the P53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990; 10:5502.
Iggo R, Gatter K, Bartek J, et al. Increased expression of mutant forms of P53 oncogene in primary lung cancer. Lancet 1990; 335:675.
Bartek J, Iggo R, Gannon J, et al. Genetic and immunohistochemical analysis of mutant P53 in human breast cancer cell lines. Oncogene 1990; 5:893.
Stretch JR, Gatter KC, Ralfkiaer E, et al. Expression of mutant P53 in melanoma. Cancer Res 1991; 51:5976.
Purdie CA, O’Grady J, Piris J, et al. P53 expression in colorectal tumors. Am J Pathol 1991; 138:807.
Albino AP. Overexpression of P53 protein in basal cell carcinomas of human skin. Am J Pathol 1992; 1:25.
Tian HS, Liu MQ, Gao WQ, et al. Induction of lung carcinoma by intralobar bronchial instillation of idoized oil in rats. Chin Med J 1984; 97(1):36.
Yu LY, Tiang HS, Shu QB, et al. Influence of superoxide dismutase on antineoplastic effect of bleomycin A5in vivo andin vitro. Chin J Oncol 1993; 3:162.
Bennett WP, Hollstein HC, He A, et al. Archival analysis of P53 genetic and protein alterations in Chinese esophageal cancer. Oncogene 1991; 6:1779.